nodes	percent_of_prediction	percent_of_DWPC	metapath
Decamethonium—BCHE—peripheral nervous system neoplasm	0.95	1	CbGaD
Decamethonium—Succinylcholine—BCHE—peripheral nervous system neoplasm	0.00482	1	CrCbGaD
Decamethonium—CHRNE—ErbB2/ErbB3 signaling events—NF2—peripheral nervous system neoplasm	0.00471	0.12	CbGpPWpGaD
Decamethonium—CHRNA1—ErbB2/ErbB3 signaling events—NF2—peripheral nervous system neoplasm	0.00237	0.0604	CbGpPWpGaD
Decamethonium—ACHE—Neurotransmitter Clearance In The Synaptic Cleft—BCHE—peripheral nervous system neoplasm	0.00224	0.0571	CbGpPWpGaD
Decamethonium—CHRNG—tongue—peripheral nervous system neoplasm	0.0018	0.286	CbGeAlD
Decamethonium—HRH3—Monoamine Transport—TH—peripheral nervous system neoplasm	0.00145	0.037	CbGpPWpGaD
Decamethonium—CHRM2—GPCRs, Other—ADGRV1—peripheral nervous system neoplasm	0.00135	0.0344	CbGpPWpGaD
Decamethonium—ACHE—Biogenic Amine Synthesis—TH—peripheral nervous system neoplasm	0.00127	0.0325	CbGpPWpGaD
Decamethonium—ACHE—Synthesis, secretion, and deacylation of Ghrelin—BCHE—peripheral nervous system neoplasm	0.00123	0.0312	CbGpPWpGaD
Decamethonium—CHRNA1—tongue—peripheral nervous system neoplasm	0.00119	0.19	CbGeAlD
Decamethonium—ACHE—Synthesis of PC—BCHE—peripheral nervous system neoplasm	0.00112	0.0286	CbGpPWpGaD
Decamethonium—CHRNE—ErbB2/ErbB3 signaling events—PTPN11—peripheral nervous system neoplasm	0.00109	0.0279	CbGpPWpGaD
Decamethonium—CHRNG—trigeminal ganglion—peripheral nervous system neoplasm	0.000894	0.142	CbGeAlD
Decamethonium—CHRNE—ErbB2/ErbB3 signaling events—ERBB2—peripheral nervous system neoplasm	0.000864	0.022	CbGpPWpGaD
Decamethonium—ACHE—Monoamine Transport—TH—peripheral nervous system neoplasm	0.000695	0.0177	CbGpPWpGaD
Decamethonium—CHRNE—ErbB2/ErbB3 signaling events—NRAS—peripheral nervous system neoplasm	0.000657	0.0168	CbGpPWpGaD
Decamethonium—HRH3—brainstem—peripheral nervous system neoplasm	0.000648	0.103	CbGeAlD
Decamethonium—ACHE—ATF-2 transcription factor network—NF1—peripheral nervous system neoplasm	0.000643	0.0164	CbGpPWpGaD
Decamethonium—CHRNG—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	0.000614	0.0156	CbGpPWpGaD
Decamethonium—CHRNE—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	0.000577	0.0147	CbGpPWpGaD
Decamethonium—CHRNA1—ErbB2/ErbB3 signaling events—PTPN11—peripheral nervous system neoplasm	0.00055	0.014	CbGpPWpGaD
Decamethonium—CHRM2—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	0.000504	0.0128	CbGpPWpGaD
Decamethonium—HRH3—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.000487	0.0124	CbGpPWpGaD
Decamethonium—CHRNE—ErbB2/ErbB3 signaling events—HRAS—peripheral nervous system neoplasm	0.000481	0.0123	CbGpPWpGaD
Decamethonium—CHRNG—Neuronal System—BCHE—peripheral nervous system neoplasm	0.00047	0.012	CbGpPWpGaD
Decamethonium—CHRNE—Neuronal System—BCHE—peripheral nervous system neoplasm	0.000442	0.0113	CbGpPWpGaD
Decamethonium—CHRNA1—ErbB2/ErbB3 signaling events—ERBB2—peripheral nervous system neoplasm	0.000435	0.0111	CbGpPWpGaD
Decamethonium—ACHE—ATF-2 transcription factor network—TH—peripheral nervous system neoplasm	0.000426	0.0109	CbGpPWpGaD
Decamethonium—CHRNE—ErbB2/ErbB3 signaling events—AKT1—peripheral nervous system neoplasm	0.000425	0.0108	CbGpPWpGaD
Decamethonium—ACHE—trigeminal ganglion—peripheral nervous system neoplasm	0.000396	0.063	CbGeAlD
Decamethonium—HRH3—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.000371	0.00945	CbGpPWpGaD
Decamethonium—HRH3—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.000355	0.00906	CbGpPWpGaD
Decamethonium—CHRND—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	0.000341	0.0087	CbGpPWpGaD
Decamethonium—ACHE—Peptide hormone metabolism—BCHE—peripheral nervous system neoplasm	0.000338	0.00862	CbGpPWpGaD
Decamethonium—ACHE—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	0.000331	0.00845	CbGpPWpGaD
Decamethonium—CHRNA1—ErbB2/ErbB3 signaling events—NRAS—peripheral nervous system neoplasm	0.000331	0.00843	CbGpPWpGaD
Decamethonium—ACHE—Glycerophospholipid biosynthesis—BCHE—peripheral nervous system neoplasm	0.000329	0.00839	CbGpPWpGaD
Decamethonium—HRH3—cerebellum—peripheral nervous system neoplasm	0.000319	0.0508	CbGeAlD
Decamethonium—CHRNA1—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	0.00029	0.0074	CbGpPWpGaD
Decamethonium—CHRNA2—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	0.000276	0.00703	CbGpPWpGaD
Decamethonium—HRH3—G alpha (i) signalling events—KNG1—peripheral nervous system neoplasm	0.000275	0.00701	CbGpPWpGaD
Decamethonium—CHRND—Neuronal System—BCHE—peripheral nervous system neoplasm	0.000262	0.00667	CbGpPWpGaD
Decamethonium—CHRNA1—ErbB2/ErbB3 signaling events—HRAS—peripheral nervous system neoplasm	0.000242	0.00617	CbGpPWpGaD
Decamethonium—HRH3—G alpha (i) signalling events—GNAS—peripheral nervous system neoplasm	0.00024	0.00613	CbGpPWpGaD
Decamethonium—ACHE—Phospholipid metabolism—BCHE—peripheral nervous system neoplasm	0.00023	0.00585	CbGpPWpGaD
Decamethonium—CHRNA1—Neuronal System—BCHE—peripheral nervous system neoplasm	0.000222	0.00567	CbGpPWpGaD
Decamethonium—HRH3—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.000219	0.00557	CbGpPWpGaD
Decamethonium—CHRNA2—cerebellum—peripheral nervous system neoplasm	0.000214	0.0341	CbGeAlD
Decamethonium—CHRNA1—ErbB2/ErbB3 signaling events—AKT1—peripheral nervous system neoplasm	0.000214	0.00545	CbGpPWpGaD
Decamethonium—CHRNA2—Neuronal System—BCHE—peripheral nervous system neoplasm	0.000211	0.00539	CbGpPWpGaD
Decamethonium—HRH3—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.000209	0.00534	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.0002	0.00509	CbGpPWpGaD
Decamethonium—CHRNB1—cerebellum—peripheral nervous system neoplasm	0.000199	0.0317	CbGeAlD
Decamethonium—BCHE—trigeminal ganglion—peripheral nervous system neoplasm	0.000195	0.031	CbGeAlD
Decamethonium—CHRNG—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	0.000192	0.00488	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.00019	0.00485	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.000182	0.00465	CbGpPWpGaD
Decamethonium—CHRNE—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	0.00018	0.00459	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000178	0.00454	CbGpPWpGaD
Decamethonium—ACHE—cerebellum—peripheral nervous system neoplasm	0.000173	0.0275	CbGeAlD
Decamethonium—BCHE—brainstem—peripheral nervous system neoplasm	0.000172	0.0274	CbGeAlD
Decamethonium—ACHE—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	0.000171	0.00435	CbGpPWpGaD
Decamethonium—HRH3—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.000167	0.00425	CbGpPWpGaD
Decamethonium—ACHE—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.000162	0.00414	CbGpPWpGaD
Decamethonium—HRH3—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.000159	0.00405	CbGpPWpGaD
Decamethonium—CHRM2—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.000158	0.00403	CbGpPWpGaD
Decamethonium—ACHE—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	0.000148	0.00377	CbGpPWpGaD
Decamethonium—HRH3—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.000146	0.00371	CbGpPWpGaD
Decamethonium—CHRM2—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	0.000145	0.0037	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.000144	0.00367	CbGpPWpGaD
Decamethonium—CHRNG—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	0.000144	0.00367	CbGpPWpGaD
Decamethonium—ACHE—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	0.000136	0.00346	CbGpPWpGaD
Decamethonium—CHRNE—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	0.000135	0.00345	CbGpPWpGaD
Decamethonium—ACHE—Integrated Pancreatic Cancer Pathway—ABCB1—peripheral nervous system neoplasm	0.000133	0.0034	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.000133	0.00339	CbGpPWpGaD
Decamethonium—CHRM2—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	0.000133	0.00339	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000132	0.00336	CbGpPWpGaD
Decamethonium—ACHE—Neuronal System—BCHE—peripheral nervous system neoplasm	0.000131	0.00333	CbGpPWpGaD
Decamethonium—CHRM2—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.00012	0.00307	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000117	0.00299	CbGpPWpGaD
Decamethonium—CHRM2—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.000115	0.00294	CbGpPWpGaD
Decamethonium—CHRM2—Calcium Regulation in the Cardiac Cell—GNAS—peripheral nervous system neoplasm	0.000113	0.00287	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000112	0.00286	CbGpPWpGaD
Decamethonium—CHRNG—Neuronal System—HRAS—peripheral nervous system neoplasm	0.00011	0.00281	CbGpPWpGaD
Decamethonium—CHRM2—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	0.000108	0.00276	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000108	0.00275	CbGpPWpGaD
Decamethonium—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	0.000107	0.00272	CbGpPWpGaD
Decamethonium—CHRNE—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000104	0.00264	CbGpPWpGaD
Decamethonium—HRH3—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	9.41e-05	0.0024	CbGpPWpGaD
Decamethonium—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	9.06e-05	0.00231	CbGpPWpGaD
Decamethonium—CHRM2—G alpha (i) signalling events—KNG1—peripheral nervous system neoplasm	8.94e-05	0.00228	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—HSD17B12—peripheral nervous system neoplasm	8.89e-05	0.00227	CbGpPWpGaD
Decamethonium—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	8.61e-05	0.00219	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	8.54e-05	0.00218	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—VIP—peripheral nervous system neoplasm	8.51e-05	0.00217	CbGpPWpGaD
Decamethonium—BCHE—cerebellum—peripheral nervous system neoplasm	8.49e-05	0.0135	CbGeAlD
Decamethonium—HRH3—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	8.23e-05	0.0021	CbGpPWpGaD
Decamethonium—CHRND—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	8.01e-05	0.00204	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—HSD17B12—peripheral nervous system neoplasm	7.93e-05	0.00202	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	7.86e-05	0.002	CbGpPWpGaD
Decamethonium—CHRM2—G alpha (i) signalling events—GNAS—peripheral nervous system neoplasm	7.82e-05	0.00199	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	7.47e-05	0.0019	CbGpPWpGaD
Decamethonium—ACHE—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	7.46e-05	0.0019	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	7.39e-05	0.00188	CbGpPWpGaD
Decamethonium—CHRM2—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	7.11e-05	0.00181	CbGpPWpGaD
Decamethonium—CHRNA1—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	6.81e-05	0.00174	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	6.81e-05	0.00174	CbGpPWpGaD
Decamethonium—ACHE—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	6.77e-05	0.00173	CbGpPWpGaD
Decamethonium—CHRNA2—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	6.47e-05	0.00165	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—GNS—peripheral nervous system neoplasm	6.43e-05	0.00164	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of proteins—BCHE—peripheral nervous system neoplasm	6.38e-05	0.00163	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—NTS—peripheral nervous system neoplasm	6.18e-05	0.00158	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—NME1—peripheral nervous system neoplasm	6.16e-05	0.00157	CbGpPWpGaD
Decamethonium—CHRND—Neuronal System—HRAS—peripheral nervous system neoplasm	6.14e-05	0.00156	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—COX2—peripheral nervous system neoplasm	5.93e-05	0.00151	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—CD55—peripheral nervous system neoplasm	5.93e-05	0.00151	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	5.9e-05	0.0015	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—GNS—peripheral nervous system neoplasm	5.73e-05	0.00146	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—NME1—peripheral nervous system neoplasm	5.5e-05	0.0014	CbGpPWpGaD
Decamethonium—CHRM2—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	5.41e-05	0.00138	CbGpPWpGaD
Decamethonium—CHRM2—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	5.41e-05	0.00138	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—COX2—peripheral nervous system neoplasm	5.29e-05	0.00135	CbGpPWpGaD
Decamethonium—ACHE—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	5.29e-05	0.00135	CbGpPWpGaD
Decamethonium—CHRNA1—Neuronal System—HRAS—peripheral nervous system neoplasm	5.22e-05	0.00133	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	5.19e-05	0.00132	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	5.16e-05	0.00132	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—KNG1—peripheral nervous system neoplasm	5.05e-05	0.00129	CbGpPWpGaD
Decamethonium—CHRNA2—Neuronal System—HRAS—peripheral nervous system neoplasm	4.96e-05	0.00126	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	4.81e-05	0.00123	CbGpPWpGaD
Decamethonium—CHRM2—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	4.73e-05	0.00121	CbGpPWpGaD
Decamethonium—CHRM2—Regulation of Actin Cytoskeleton—NRAS—peripheral nervous system neoplasm	4.7e-05	0.0012	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—VIP—peripheral nervous system neoplasm	4.68e-05	0.00119	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—GNAS—peripheral nervous system neoplasm	4.41e-05	0.00113	CbGpPWpGaD
Decamethonium—ACHE—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	4.34e-05	0.00111	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	4.32e-05	0.0011	CbGpPWpGaD
Decamethonium—ACHE—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	4e-05	0.00102	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—ENO2—peripheral nervous system neoplasm	3.89e-05	0.000993	CbGpPWpGaD
Decamethonium—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	3.67e-05	0.000935	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—NTS—peripheral nervous system neoplasm	3.65e-05	0.000931	CbGpPWpGaD
Decamethonium—BCHE—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	3.57e-05	0.00091	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CD55—peripheral nervous system neoplasm	3.5e-05	0.000893	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—ENO2—peripheral nervous system neoplasm	3.47e-05	0.000886	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—BCHE—peripheral nervous system neoplasm	3.29e-05	0.000839	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.14e-05	0.0008	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	3.12e-05	0.000796	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—TH—peripheral nervous system neoplasm	3.09e-05	0.000789	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	3.07e-05	0.000782	CbGpPWpGaD
Decamethonium—ACHE—Neuronal System—HRAS—peripheral nervous system neoplasm	3.07e-05	0.000782	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	3.06e-05	0.00078	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.8e-05	0.000714	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	2.78e-05	0.000708	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—VIP—peripheral nervous system neoplasm	2.77e-05	0.000706	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—TH—peripheral nervous system neoplasm	2.76e-05	0.000704	CbGpPWpGaD
Decamethonium—BCHE—Neuronal System—HRAS—peripheral nervous system neoplasm	2.74e-05	0.000697	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	2.67e-05	0.000682	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	2.55e-05	0.000651	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—GNAS—peripheral nervous system neoplasm	2.53e-05	0.000644	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—ABCB1—peripheral nervous system neoplasm	2.48e-05	0.000632	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	2.43e-05	0.000619	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.42e-05	0.000618	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.28e-05	0.000582	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—GNAS—peripheral nervous system neoplasm	2.25e-05	0.000574	CbGpPWpGaD
Decamethonium—HRH3—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.22e-05	0.000566	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—ABCB1—peripheral nervous system neoplasm	2.21e-05	0.000564	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.2e-05	0.000561	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.02e-05	0.000514	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.92e-05	0.000489	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.84e-05	0.00047	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.72e-05	0.000438	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.69e-05	0.00043	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.64e-05	0.000418	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.56e-05	0.000399	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.43e-05	0.000366	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.41e-05	0.00036	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.35e-05	0.000344	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.19e-05	0.000304	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.01e-05	0.000259	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	9.97e-06	0.000254	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	7.88e-06	0.000201	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	7.42e-06	0.000189	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	7.22e-06	0.000184	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	7.15e-06	0.000182	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—AKT1—peripheral nervous system neoplasm	6.82e-06	0.000174	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	6.56e-06	0.000167	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—AKT1—peripheral nervous system neoplasm	6.08e-06	0.000155	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	6e-06	0.000153	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.58e-06	0.000142	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.59e-06	0.000117	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.39e-06	0.000112	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.87e-06	9.87e-05	CbGpPWpGaD
